{
    "Trade/Device Name(s)": [
        "ABL90 FLEX",
        "ABL90 FLEX analyzer"
    ],
    "Submitter Information": "Radiometer Medical ApS",
    "510(k) Number": "K132691",
    "Predicate Device Reference 510(k) Number(s)": [
        "K050869"
    ],
    "Regulatory Class": "I, reserved",
    "Product Code(s)": [
        "MQM"
    ],
    "Summary Letter Date": "October 24, 2014",
    "Summary Letter Received Date": "October 31, 2014",
    "Submission Date": "November 11, 2014",
    "Regulation Number(s)": [
        "21 CFR 862.1113"
    ],
    "Regulation Name(s)": [
        "Bilirubin (total and unbound) in the neonate test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Neonatal bilirubin"
    ],
    "Specimen Type(s)": [
        "Heparinised capillary whole blood"
    ],
    "Specimen Container(s)": [
        "Capillary",
        "Syringe"
    ],
    "Instrument(s)/Platform(s)": [
        "ABL90 FLEX analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Spectrophotometric multi-component analysis",
        "Co-Oximetry module"
    ],
    "Methodologies": [
        "Spectrophotometry"
    ],
    "Submission Type(s)": [
        "Analyzer",
        "Instrument",
        "Automated system"
    ],
    "Document Summary": "FDA 510(k) summary for ABL90 FLEX analyzer with added neonatal bilirubin measurement by spectrophotometry in whole blood.",
    "Indications for Use Summary": "Quantitative measurement of neonatal bilirubin in heparinised capillary whole blood to aid in assessing the risk of kernicterus in neonates, for use in laboratory, near patient, or point-of-care settings under physician's order.",
    "fda_folder": "Clinical Chemistry"
}